Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.

MLA

Cheema, Parneet K., et al. “Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Current Oncology, vol. 31, no. 10, Oct. 2024, pp. 6356–83. EBSCOhost, https://doi.org/10.3390/curroncol31100473.

APA

Cheema, P. K., Iafolla, M. A. J., Abdel-Qadir, H., Bellini, A. B., Chatur, N., Chandok, N., Comondore, V. R., Cunningham, M., Halperin, I., Hu, A. B., Jaskolka, D., Darvish-Kazem, S., Khandaker, M. H., Kitchlu, A., Sachdeva, J. S., Shapera, S., Woolnough, N. R. J., & Nematollahi, M. (2024). Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(10), 6356–6383. https://doi.org/10.3390/curroncol31100473

Chicago

Cheema, Parneet K., Marco A. J. Iafolla, Husam Abdel-Qadir, Andrew B. Bellini, Nazira Chatur, Natasha Chandok, Vikram R. Comondore, et al. 2024. “Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Current Oncology 31 (10): 6356–83. doi:10.3390/curroncol31100473.